| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 9.52e-07 | 8 | 219 | 4 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 2.81e-06 | 10 | 219 | 4 | GO:0140999 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 1.28e-05 | 5 | 219 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 5.94e-05 | 20 | 219 | 4 | GO:0042800 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.16e-04 | 44 | 219 | 5 | GO:0140938 | |
| GeneOntologyMolecularFunction | unmethylated CpG binding | 1.48e-04 | 10 | 219 | 3 | GO:0045322 | |
| GeneOntologyMolecularFunction | potassium channel inhibitor activity | 2.01e-04 | 11 | 219 | 3 | GO:0019870 | |
| GeneOntologyMolecularFunction | NuRD complex binding | 3.57e-04 | 3 | 219 | 2 | GO:0120325 | |
| GeneOntologyMolecularFunction | titin binding | 4.33e-04 | 14 | 219 | 3 | GO:0031432 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP24 SIPA1L3 TBC1D2 OBSCN ARHGEF17 CDC42EP2 SESN2 ARAP2 PLEKHG7 ARHGEF5 ARHGEF25 ARHGEF33 TNK2 RINL GDPGP1 | 5.02e-04 | 507 | 219 | 15 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP24 SIPA1L3 TBC1D2 OBSCN ARHGEF17 CDC42EP2 SESN2 ARAP2 PLEKHG7 ARHGEF5 ARHGEF25 ARHGEF33 TNK2 RINL GDPGP1 | 5.02e-04 | 507 | 219 | 15 | GO:0030695 |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 9.02e-04 | 68 | 219 | 5 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 9.64e-04 | 69 | 219 | 5 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone modifying activity | 9.92e-04 | 229 | 219 | 9 | GO:0140993 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 1.10e-03 | 71 | 219 | 5 | GO:0042054 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 1.24e-03 | 43 | 219 | 4 | GO:0008307 | |
| GeneOntologyBiologicalProcess | gamete generation | SETX KMT2B USP9X INPP5B SPATA31A7 ETV6 SPATA31A6 PGR PRDM1 SPATA31D4 SPATA31D1 SPATA31D3 GLI1 RIMBP3C CFAP70 GNAS SPOCD1 SPATA31A3 ATN1 SHBG SPATA31C2 ZMIZ1 SPATA31A5 RIMBP3 KMT2D SPATA31A1 MCM9 CCDC87 FMN2 SOHLH1 TNK2 CFAP61 SPAG17 RIMBP3B OAZ3 | 2.90e-10 | 982 | 219 | 35 | GO:0007276 |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | SETX KMT2B HDAC4 USP9X INPP5B SPATA31A7 ETV6 DCST2 SPATA31A6 PGR PRDM1 SPATA31D4 SPATA31D1 SPATA31D3 GLI1 RIMBP3C CFAP70 GNAS DMD SPOCD1 SPATA31A3 ATN1 SHBG SPATA31C2 ZMIZ1 SPATA31A5 RIMBP3 KMT2D ARRB2 SPATA31A1 MCM9 CCDC87 FMN2 SOHLH1 TNK2 CFAP61 SPAG17 RIMBP3B OAZ3 | 3.08e-10 | 1194 | 219 | 39 | GO:0048609 |
| GeneOntologyBiologicalProcess | sexual reproduction | SETX KMT2B USP9X INPP5B SPATA31A7 ETV6 DCST2 SPATA31A6 PGR PRDM1 SPATA31D4 SPATA31D1 SPATA31D3 FCRL3 GLI1 RIMBP3C CFAP70 GNAS SPOCD1 SPATA31A3 ATN1 SHBG SPATA31C2 ZMIZ1 SPATA31A5 RIMBP3 KMT2D SPATA31A1 MCM9 CCDC87 FMN2 SOHLH1 TNK2 CFAP61 SPAG17 RIMBP3B OAZ3 SLX4 | 1.46e-08 | 1312 | 219 | 38 | GO:0019953 |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | SETX KMT2B INPP5B SPATA31A7 SPATA31A6 PGR PRDM1 SPATA31D4 SPATA31D1 SPATA31D3 GLI1 RIMBP3C CFAP70 GNAS SPOCD1 HECTD1 SPATA31A3 ATN1 SHBG SPATA31C2 SPATA31A5 RIMBP3 KMT2D ARRB2 CSF1 SPATA31A1 DACH2 CCDC87 FMN2 SOHLH1 TNK2 CFAP61 SPAG17 RIMBP3B OAZ3 | 1.01e-07 | 1235 | 219 | 35 | GO:0003006 |
| GeneOntologyBiologicalProcess | spermatogenesis | SETX INPP5B SPATA31A7 SPATA31A6 SPATA31D4 SPATA31D1 SPATA31D3 GLI1 RIMBP3C CFAP70 SPOCD1 SPATA31A3 ATN1 SHBG SPATA31C2 SPATA31A5 RIMBP3 SPATA31A1 CCDC87 SOHLH1 TNK2 CFAP61 SPAG17 RIMBP3B OAZ3 | 3.88e-07 | 744 | 219 | 25 | GO:0007283 |
| GeneOntologyBiologicalProcess | male gamete generation | SETX INPP5B SPATA31A7 SPATA31A6 SPATA31D4 SPATA31D1 SPATA31D3 GLI1 RIMBP3C CFAP70 SPOCD1 SPATA31A3 ATN1 SHBG SPATA31C2 SPATA31A5 RIMBP3 SPATA31A1 CCDC87 SOHLH1 TNK2 CFAP61 SPAG17 RIMBP3B OAZ3 | 6.02e-07 | 762 | 219 | 25 | GO:0048232 |
| GeneOntologyBiologicalProcess | positive regulation of termination of DNA-templated transcription | 1.12e-04 | 2 | 219 | 2 | GO:0060566 | |
| GeneOntologyBiologicalProcess | positive regulation of termination of RNA polymerase II transcription | 1.12e-04 | 2 | 219 | 2 | GO:1904595 | |
| GeneOntologyCellularComponent | manchette | 1.02e-05 | 28 | 221 | 5 | GO:0002177 | |
| GeneOntologyCellularComponent | nuclear body | AMER1 SETX SETD1B HDAC4 LSG1 MBD1 OBSCN ANKS1B GON4L RREB1 NCAPG2 ADD1 ANKRD2 HECTD1 TREML1 USP36 ZNF473 MSL1 SIM2 SPAG5 PIAS4 CSF1 BAZ2A CDK13 MDC1 | 1.13e-05 | 903 | 221 | 25 | GO:0016604 |
| GeneOntologyCellularComponent | outer dynein arm | 2.39e-04 | 12 | 221 | 3 | GO:0036157 | |
| HumanPheno | Abnormal calvaria morphology | ASXL1 ZNF142 AMER1 SETD1B KMT2B HDAC4 USP9X APC2 RREB1 WNK1 NCAPG2 LUZP1 TCEAL1 RUSC2 BRAF ARL13B KMT2A PACS2 GNAS MN1 ATN1 NEDD4L PCLO PIGQ SETD2 KMT2D SLC25A12 CDK13 DCHS1 ANKRD11 PTCH2 AUTS2 PAK2 PRKAR1B KAT6B SLX4 SMAD3 | 2.74e-06 | 1254 | 75 | 37 | HP:0002683 |
| HumanPheno | Delayed speech and language development | ASXL1 ZNF142 AMER1 SETD1B REPS1 KMT2B HDAC4 USP9X NEXMIF APC2 NCAPG2 LUZP1 TCEAL1 RUSC2 KCNQ5 ARL13B KMT2A PACS2 GNAS DMD MN1 DNAH9 ATN1 NEDD4L ZMIZ1 SETD2 KMT2D SLC25A12 CDK13 ANKRD11 AUTS2 PRKAR1B FMN2 KAT6B | 5.40e-06 | 1123 | 75 | 34 | HP:0000750 |
| HumanPheno | Patent ductus arteriosus | AMER1 KMT2B HDAC4 USP9X APC2 RREB1 NCAPG2 LUZP1 BRAF KMT2A DNAH9 NEDD4L ZMIZ1 KMT2D PAK2 KAT6B SLX4 SMAD3 | 6.73e-06 | 382 | 75 | 18 | HP:0001643 |
| HumanPheno | Abnormality of calvarial morphology | ASXL1 ZNF142 AMER1 SETD1B KMT2B HDAC4 USP9X APC2 RREB1 NCAPG2 LUZP1 TCEAL1 RUSC2 BRAF ARL13B KMT2A PACS2 MN1 ATN1 NEDD4L PCLO PIGQ SETD2 KMT2D SLC25A12 CDK13 ANKRD11 PTCH2 AUTS2 PAK2 PRKAR1B KAT6B SLX4 SMAD3 | 6.79e-06 | 1134 | 75 | 34 | HP:0002648 |
| HumanPheno | Language impairment | ASXL1 ZNF142 AMER1 SETD1B REPS1 KMT2B HDAC4 USP9X NEXMIF APC2 NCAPG2 LUZP1 TCEAL1 RUSC2 KCNQ5 ARL13B KMT2A PACS2 GNAS DMD MN1 DNAH9 ATN1 NEDD4L ZMIZ1 SETD2 KMT2D SLC25A12 CDK13 ANKRD11 AUTS2 PRKAR1B FMN2 KAT6B | 1.63e-05 | 1178 | 75 | 34 | HP:0002463 |
| HumanPheno | Gray matter heterotopias | 2.87e-05 | 42 | 75 | 6 | HP:0002281 | |
| HumanPheno | Periventricular heterotopia | 2.87e-05 | 42 | 75 | 6 | HP:0007165 | |
| HumanPheno | Short palpebral fissure | 6.40e-05 | 122 | 75 | 9 | HP:0012745 | |
| HumanPheno | Abnormal size of the palpebral fissures | HDAC4 USP9X BRAF KMT2A PCLO SETD2 KMT2D CDK13 DCHS1 ANKRD11 AUTS2 PRKAR1B KAT6B SLX4 | 8.84e-05 | 298 | 75 | 14 | HP:0200007 |
| HumanPheno | Abnormal eating behavior | 9.32e-05 | 128 | 75 | 9 | HP:0100738 | |
| HumanPheno | Abnormal nasal tip morphology | KMT2B HDAC4 USP9X RREB1 RUSC2 BRAF KMT2A ATN1 PIGQ SETD2 KMT2D CDK13 AUTS2 PRKAR1B KAT6B SLX4 | 1.16e-04 | 386 | 75 | 16 | HP:0000436 |
| HumanPheno | Long fingers | ASXL1 AMER1 SETD1B USP9X RREB1 WNK1 RUSC2 ZNF469 KMT2A ZMIZ1 SLC25A12 PTCH2 PRKAR1B SMAD3 | 1.18e-04 | 306 | 75 | 14 | HP:0100807 |
| HumanPheno | Gastroesophageal reflux | ASXL1 AMER1 KMT2B USP9X NEXMIF APC2 RREB1 WNK1 LUZP1 TCEAL1 BRAF KMT2A PACS2 GNAS ATN1 NEDD4L KMT2D CDK13 KAT6B | 1.20e-04 | 517 | 75 | 19 | HP:0002020 |
| HumanPheno | Polyphagia | 1.29e-04 | 78 | 75 | 7 | HP:0002591 | |
| HumanPheno | Bulbous nose | KMT2B USP9X RREB1 RUSC2 BRAF KMT2A ATN1 KMT2D CDK13 KAT6B SLX4 | 1.46e-04 | 201 | 75 | 11 | HP:0000414 |
| HumanPheno | Abnormal hand morphology | ASXL1 AMER1 KMT2B HDAC4 USP9X NEXMIF APC2 PTPN22 RREB1 WNK1 LUZP1 BRAF GLI1 ARL13B KMT2A PACS2 GNAS IQCE ATN1 NEDD4L ZMIZ1 PIGQ SETD2 KMT2D DCHS1 ANKRD11 PTCH2 AUTS2 KAT6B SLX4 | 1.58e-04 | 1082 | 75 | 30 | HP:0005922 |
| HumanPheno | Congenital malformation of the great arteries | AMER1 KMT2B HDAC4 USP9X APC2 PTPN22 RREB1 NCAPG2 LUZP1 BRAF KMT2A DNAH9 NEDD4L ZMIZ1 KMT2D PAK2 KAT6B SLX4 SMAD3 | 1.63e-04 | 529 | 75 | 19 | HP:0011603 |
| HumanPheno | Highly arched eyebrow | HDAC4 NCAPG2 RUSC2 ARL13B KMT2A MN1 SETD2 KMT2D CDK13 ANKRD11 AUTS2 | 1.82e-04 | 206 | 75 | 11 | HP:0002553 |
| HumanPheno | Tapered finger | 1.96e-04 | 141 | 75 | 9 | HP:0001182 | |
| HumanPheno | Abnormal finger morphology | ASXL1 AMER1 SETD1B KMT2B HDAC4 USP9X NEXMIF APC2 PTPN22 RREB1 WNK1 LUZP1 RUSC2 ZNF469 BRAF GLI1 ARL13B KMT2A PACS2 GNAS DNAH9 IQCE ATN1 NEDD4L ZMIZ1 PIGQ KMT2D SLC25A12 ANKRD11 PTCH2 AUTS2 PRKAR1B KAT6B SLX4 SMAD3 | 2.17e-04 | 1385 | 75 | 35 | HP:0001167 |
| HumanPheno | Abnormal toe morphology | ASXL1 AMER1 KMT2B HDAC4 USP9X APC2 RREB1 WNK1 LUZP1 ITPR3 ZNF469 GLI1 ARL13B KMT2A GNAS IQCE ATN1 NEDD4L ZMIZ1 PIGQ KMT2D PTCH2 AUTS2 KAT6B SLX4 SMAD3 | 2.49e-04 | 893 | 75 | 26 | HP:0001780 |
| HumanPheno | Astigmatism | KMT2B HDAC4 USP9X APC2 TCEAL1 PACS2 ZMIZ1 PIGQ ANKRD11 PRKAR1B SLX4 | 2.87e-04 | 217 | 75 | 11 | HP:0000483 |
| HumanPheno | Wide nasal bridge | ASXL1 AMER1 USP9X NEXMIF APC2 RREB1 LUZP1 BRAF KMT2A PACS2 ZMIZ1 SETD2 KMT2D CDK13 DCHS1 PTCH2 AUTS2 KAT6B | 2.99e-04 | 508 | 75 | 18 | HP:0000431 |
| MousePheno | abnormal parietal bone morphology | 1.03e-05 | 64 | 166 | 7 | MP:0000109 | |
| Domain | DUF4599 | SPATA31A7 SPATA31A6 SPATA31D4 SPATA31D1 SPATA31D3 SPATA31A3 SPATA31C2 SPATA31A5 | 1.44e-13 | 12 | 218 | 8 | PF15371 |
| Domain | DUF4599 | SPATA31A7 SPATA31A6 SPATA31D4 SPATA31D1 SPATA31D3 SPATA31A3 SPATA31C2 SPATA31A5 | 1.44e-13 | 12 | 218 | 8 | IPR027970 |
| Domain | Post-SET_dom | 8.14e-07 | 16 | 218 | 5 | IPR003616 | |
| Domain | PostSET | 8.14e-07 | 16 | 218 | 5 | SM00508 | |
| Domain | POST_SET | 8.14e-07 | 16 | 218 | 5 | PS50868 | |
| Domain | FAM47 | 6.22e-06 | 4 | 218 | 3 | PF14642 | |
| Domain | FAM47 | 6.22e-06 | 4 | 218 | 3 | IPR032743 | |
| Domain | SET | 7.55e-06 | 41 | 218 | 6 | PF00856 | |
| Domain | SET | 1.50e-05 | 46 | 218 | 6 | SM00317 | |
| Domain | FYrich_C | 1.54e-05 | 5 | 218 | 3 | IPR003889 | |
| Domain | FYrich_N | 1.54e-05 | 5 | 218 | 3 | IPR003888 | |
| Domain | FYRC | 1.54e-05 | 5 | 218 | 3 | SM00542 | |
| Domain | FYRN | 1.54e-05 | 5 | 218 | 3 | SM00541 | |
| Domain | FYRN | 1.54e-05 | 5 | 218 | 3 | PF05964 | |
| Domain | FYRC | 1.54e-05 | 5 | 218 | 3 | PF05965 | |
| Domain | FYRC | 1.54e-05 | 5 | 218 | 3 | PS51543 | |
| Domain | FYRN | 1.54e-05 | 5 | 218 | 3 | PS51542 | |
| Domain | SET_dom | 2.44e-05 | 50 | 218 | 6 | IPR001214 | |
| Domain | SET | 2.44e-05 | 50 | 218 | 6 | PS50280 | |
| Domain | MeTrfase_trithorax | 1.36e-04 | 2 | 218 | 2 | IPR016569 | |
| Domain | Znf_piccolo | 1.36e-04 | 2 | 218 | 2 | IPR008899 | |
| Domain | zf-piccolo | 1.36e-04 | 2 | 218 | 2 | PF05715 | |
| Domain | RhoGEF | 1.41e-04 | 68 | 218 | 6 | SM00325 | |
| Domain | RhoGEF | 1.66e-04 | 70 | 218 | 6 | PF00621 | |
| Domain | DH_2 | 1.66e-04 | 70 | 218 | 6 | PS50010 | |
| Domain | - | 1.80e-04 | 71 | 218 | 6 | 1.20.900.10 | |
| Domain | DH-domain | 1.80e-04 | 71 | 218 | 6 | IPR000219 | |
| Domain | ZF_CXXC | 2.42e-04 | 11 | 218 | 3 | PS51058 | |
| Domain | Znf_CXXC | 2.42e-04 | 11 | 218 | 3 | IPR002857 | |
| Domain | zf-CXXC | 2.42e-04 | 11 | 218 | 3 | PF02008 | |
| Domain | FHA | 2.97e-04 | 28 | 218 | 4 | SM00240 | |
| Domain | SH3_9 | 3.01e-04 | 78 | 218 | 6 | PF14604 | |
| Domain | Znf_FYVE_PHD | 3.37e-04 | 147 | 218 | 8 | IPR011011 | |
| Domain | SMAD_FHA_domain | 3.44e-04 | 52 | 218 | 5 | IPR008984 | |
| Domain | FHA | 4.44e-04 | 31 | 218 | 4 | PF00498 | |
| Domain | FN3 | 5.65e-04 | 199 | 218 | 9 | PS50853 | |
| Domain | Znf_PHD | 6.89e-04 | 91 | 218 | 6 | IPR001965 | |
| Domain | - | 7.94e-04 | 36 | 218 | 4 | 2.60.200.20 | |
| Domain | FHA_dom | 7.94e-04 | 36 | 218 | 4 | IPR000253 | |
| Domain | FN3_dom | 8.03e-04 | 209 | 218 | 9 | IPR003961 | |
| Domain | DH_1 | 8.39e-04 | 63 | 218 | 5 | PS00741 | |
| Domain | ZF_PHD_2 | 8.65e-04 | 95 | 218 | 6 | PS50016 | |
| Domain | ZF_PHD_1 | 9.14e-04 | 96 | 218 | 6 | PS01359 | |
| Domain | SH3 | 1.01e-03 | 216 | 218 | 9 | SM00326 | |
| Domain | SH3 | 1.01e-03 | 216 | 218 | 9 | PS50002 | |
| Domain | SH3_domain | 1.15e-03 | 220 | 218 | 9 | IPR001452 | |
| Domain | FN3 | 1.52e-03 | 185 | 218 | 8 | SM00060 | |
| Domain | CRIB | 1.54e-03 | 20 | 218 | 3 | PS50108 | |
| Domain | Ig-like_fold | BOC PDCD1 OBSCN SIGLEC15 BTN3A3 CILP2 FCRL3 RIMBP3C MYBPHL TREML1 ISLR2 BCAN RIMBP3 SNED1 CSF2RB IGHA2 RIMBP3B MYBPC3 | 1.63e-03 | 706 | 218 | 18 | IPR013783 |
| Domain | CRIB_dom | 1.79e-03 | 21 | 218 | 3 | IPR000095 | |
| Domain | PHD | 1.84e-03 | 75 | 218 | 5 | PF00628 | |
| Domain | Acyl_CoA_acyltransferase | 1.85e-03 | 45 | 218 | 4 | IPR016181 | |
| Domain | OSR1_C | 1.97e-03 | 6 | 218 | 2 | PF12202 | |
| Domain | Myb-like_dom | 1.97e-03 | 6 | 218 | 2 | IPR017877 | |
| Domain | Kinase_OSR1/WNK_CCT | 1.97e-03 | 6 | 218 | 2 | IPR024678 | |
| Domain | WxxW_domain | 1.97e-03 | 6 | 218 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 1.97e-03 | 6 | 218 | 2 | PF13330 | |
| Domain | EPHD | 2.05e-03 | 22 | 218 | 3 | PS51805 | |
| Domain | - | BOC PDCD1 OBSCN SIGLEC15 BTN3A3 CILP2 FCRL3 RIMBP3C MYBPHL TREML1 ISLR2 BCAN RIMBP3 SNED1 CSF2RB RIMBP3B MYBPC3 | 2.06e-03 | 663 | 218 | 17 | 2.60.40.10 |
| Domain | Znf_PHD-finger | 2.32e-03 | 79 | 218 | 5 | IPR019787 | |
| Domain | WW | 2.35e-03 | 48 | 218 | 4 | SM00456 | |
| Pathway | REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION | 3.26e-05 | 7 | 140 | 3 | M27501 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 3.47e-05 | 38 | 140 | 5 | MM17073 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 5.69e-05 | 42 | 140 | 5 | M48018 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 8.89e-05 | 46 | 140 | 5 | MM14933 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 1.25e-04 | 150 | 140 | 8 | M27440 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 1.61e-04 | 52 | 140 | 5 | MM14743 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | EPPK1 HDAC4 ACACB APC2 PTPN22 WNK1 APOBR TMEM132C ZNF469 BSN WNK2 IQCE TMEM139 PRUNE2 ATN1 NEDD4L ARHGEF5 ARRB2 MDC1 CCDC87 TNK2 | 9.78e-13 | 430 | 225 | 21 | 35044719 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TNK1 AMER1 SETX HDAC4 LSG1 SIPA1L3 MBD1 ARHGEF17 WNK1 LUZP1 RUSC2 CEP170 MYLK3 KCNQ5 BRAF STARD9 KMT2A HELZ GNAS HECTD1 ARAP2 KIF13B NEDD4L ARHGEF5 LPIN3 ANKRD11 FMN2 AKAP11 | 2.81e-12 | 861 | 225 | 28 | 36931259 |
| Pubmed | 6.47e-11 | 6 | 225 | 5 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 6.47e-11 | 6 | 225 | 5 | 25930072 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | KMT2B HDAC4 ACACB RREB1 ZNF512B GSE1 KMT2A TADA2A HOMEZ ATN1 ZMIZ1 PIAS4 KMT2D MDC1 AUTS2 SLX4 | 1.46e-09 | 351 | 225 | 16 | 38297188 |
| Pubmed | KMT2B ARHGEF17 WNK1 NACAD RUSC2 DNAH9 PRUNE2 BAZ2A KAT6B ZNF646 | 1.61e-09 | 104 | 225 | 10 | 9205841 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPPK1 SETD1B REPS1 KMT2B SIPA1L3 OBSCN WNK1 ZDHHC8 ITPR3 GLI1 MMP17 HECTD1 BCL2L13 WNK2 IQCE SEMA6C BAHD1 PIAS4 LPIN3 KMT2D ADAMTS7 ZNF827 CDK13 ANKRD11 TNK2 DISP2 SNAPC4 | 3.80e-09 | 1105 | 225 | 27 | 35748872 |
| Pubmed | SETX NACAD ZNF512B ANKIB1 BSN WNK2 IQCE HOMEZ USP36 SEMA6C ISLR2 BAHD1 KIAA1614 MDC1 AUTS2 AKAP11 KAT6B ZNF646 | 1.33e-08 | 529 | 225 | 18 | 14621295 | |
| Pubmed | ZNF142 SETX HDAC4 WNK1 BRAF CDC42EP2 HELZ CCDC97 DMD WNK2 TOM1L2 NEDD4L ARRB2 PAK2 PRKAR1B TNK2 HERPUD1 | 2.29e-08 | 486 | 225 | 17 | 20936779 | |
| Pubmed | SIPA1L3 DHX38 WNK1 CEP170 PWWP2A FAT2 HECTD1 PRUNE2 KIF13B ZNF473 SETD2 CDK13 DNAH17 SCIN HERPUD1 SLX4 MAST3 | 2.82e-08 | 493 | 225 | 17 | 15368895 | |
| Pubmed | LSG1 MBD1 RREB1 LUZP1 ZNF512B CEP170 ZNF469 GSE1 ANKRD2 HELZ TADA2A ARAP2 USP36 ISLR2 ATN1 SETD2 ARHGEF33 SLC25A12 ZNF827 BAZ2A CBY2 FMN2 KAT6B WDTC1 ZNF646 | 7.99e-08 | 1116 | 225 | 25 | 31753913 | |
| Pubmed | 1.17e-07 | 8 | 225 | 4 | 22266653 | ||
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 1.17e-07 | 8 | 225 | 4 | 23130995 | |
| Pubmed | 1.17e-07 | 19 | 225 | 5 | 37516749 | ||
| Pubmed | 2.10e-07 | 9 | 225 | 4 | 22665483 | ||
| Pubmed | 2.67e-07 | 3 | 225 | 3 | 18591455 | ||
| Pubmed | 2.96e-07 | 42 | 225 | 6 | 23444366 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SETX SETD1B USP9X DHX38 WNK1 LUZP1 GSE1 HELZ GNAS BSN KIF13B RIMBP3 PIAS4 SETD2 WDCP SCIN SLX4 | 3.43e-07 | 588 | 225 | 17 | 38580884 |
| Pubmed | 4.17e-07 | 24 | 225 | 5 | 32212159 | ||
| Pubmed | ASXL1 SETD1B GON4L ARHGEF17 RUSC2 SEMA6D GSE1 STARD9 PACS2 ARAP2 NEDD4L WDR47 BAZ2A DISP2 | 5.02e-07 | 407 | 225 | 14 | 12693553 | |
| Pubmed | 8.11e-07 | 12 | 225 | 4 | 27563068 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KMT2B TBC1D2 RREB1 ADD1 GSE1 BRAF KMT2A PACS2 HELZ MN1 HOMEZ ATN1 SETD2 KMT2D BAZ2A CDK13 MDC1 SNAPC4 KAT6B | 8.21e-07 | 774 | 225 | 19 | 15302935 |
| Pubmed | 9.34e-07 | 157 | 225 | 9 | 30186101 | ||
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 1.06e-06 | 4 | 225 | 3 | 23129768 | |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 1.06e-06 | 4 | 225 | 3 | 19091768 | |
| Pubmed | SETX LSG1 DHX38 GON4L NCAPG2 RUSC2 GSE1 ANKIB1 KMT2A HELZ ATN1 ARHGEF5 SPAG5 CEMIP LPIN3 CDK13 WDCP | 1.36e-06 | 650 | 225 | 17 | 38777146 | |
| Pubmed | 1.89e-06 | 57 | 225 | 6 | 18022353 | ||
| Pubmed | 2.65e-06 | 5 | 225 | 3 | 26320581 | ||
| Pubmed | 2.65e-06 | 5 | 225 | 3 | 25561738 | ||
| Pubmed | MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia. | 2.65e-06 | 5 | 225 | 3 | 28609655 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 2.65e-06 | 5 | 225 | 3 | 17855024 | |
| Pubmed | NACAD SPATA31D4 SPATA31D3 KCNQ5 STARD9 ANKIB1 BSN WNK2 IQCE MCM9 | 3.20e-06 | 233 | 225 | 10 | 37704626 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CPAMD8 AMER1 HDAC4 SIPA1L3 OBSCN FOXN3 MAP3K12 CEP170 KCNQ5 ANKIB1 GNAS HECTD1 WNK2 PRUNE2 NEDD4L ZDHHC14 ZMIZ1 PIAS4 ARRB2 ZNF827 CDK13 ANKRD11 AUTS2 PRKAR1B TNK2 KAT6B | 4.66e-06 | 1489 | 225 | 26 | 28611215 |
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 4.74e-06 | 102 | 225 | 7 | 15778465 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | ASXL1 SETD1B KMT2B RREB1 ZNF512B PWWP2A GSE1 KMT2A SESN2 TADA2A ATN1 MSL1 KMT2D AUTS2 | 4.91e-06 | 495 | 225 | 14 | 27705803 |
| Pubmed | MLL associates specifically with a subset of transcriptionally active target genes. | 5.27e-06 | 6 | 225 | 3 | 16199523 | |
| Pubmed | 5.27e-06 | 6 | 225 | 3 | 16386788 | ||
| Pubmed | Cleavage of TFIIA by Taspase1 activates TRF2-specified mammalian male germ cell programs. | 5.27e-06 | 6 | 225 | 3 | 24176642 | |
| Pubmed | 9.17e-06 | 7 | 225 | 3 | 20525693 | ||
| Pubmed | 1.14e-05 | 22 | 225 | 4 | 28380258 | ||
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 1.14e-05 | 22 | 225 | 4 | 26886794 | |
| Pubmed | A Conserved Role for Girdin in Basal Body Positioning and Ciliogenesis. | 1.46e-05 | 8 | 225 | 3 | 27623382 | |
| Pubmed | The mutational landscape of lethal castration-resistant prostate cancer. | 1.46e-05 | 8 | 225 | 3 | 22722839 | |
| Pubmed | KMT2B ACACB RREB1 LUZP1 GSE1 TADA2A HOMEZ ZMIZ1 SPAG5 KMT2D ARRB2 WDCP | 2.03e-05 | 418 | 225 | 12 | 34709266 | |
| Pubmed | Proteolysis of MLL family proteins is essential for taspase1-orchestrated cell cycle progression. | 2.18e-05 | 9 | 225 | 3 | 16951254 | |
| Pubmed | 2.33e-05 | 130 | 225 | 7 | 12421765 | ||
| Pubmed | SETD1B KMT2B USP9X APC2 WNK1 CFD BRAF KMT2A MMP17 BCL2L13 WNK2 PIAS4 CDK13 DNAH17 PAK2 KAT6B | 2.49e-05 | 730 | 225 | 16 | 34857952 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | AMER1 SIPA1L3 PTPN22 CEP170 ERFE GSE1 DNAH9 USP36 SHROOM1 CDK13 MDC1 | 2.63e-05 | 361 | 225 | 11 | 26167880 |
| Pubmed | 3.09e-05 | 28 | 225 | 4 | 31719045 | ||
| Pubmed | DNA Sequence Recognition of Human CXXC Domains and Their Structural Determinants. | 3.10e-05 | 10 | 225 | 3 | 29276034 | |
| Pubmed | 3.10e-05 | 242 | 225 | 9 | 34011540 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SETD1B LSG1 USP9X DHX38 ITPR3 CEP170 HECTD1 POLR2I SETD2 WDCP MDC1 SLX4 | 3.35e-05 | 440 | 225 | 12 | 34244565 |
| Pubmed | Primary cilia deficiency in neural crest cells models anterior segment dysgenesis in mouse. | 3.57e-05 | 29 | 225 | 4 | 31845891 | |
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 4.17e-05 | 2 | 225 | 2 | 23403927 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 32575385 | ||
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 4.17e-05 | 2 | 225 | 2 | 26793095 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 35640156 | ||
| Pubmed | MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity. | 4.17e-05 | 2 | 225 | 2 | 29777171 | |
| Pubmed | Active zone density is conserved during synaptic growth but impaired in aged mice. | 4.17e-05 | 2 | 225 | 2 | 21935939 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 19403693 | ||
| Pubmed | Myeloid neoplasms with t(12;22)(p13;q12)/MN1-EVT6: a systematic review of 12 cases. | 4.17e-05 | 2 | 225 | 2 | 29273914 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 24423662 | ||
| Pubmed | Dual leucine zipper kinase is required for mechanical allodynia and microgliosis after nerve injury. | 4.17e-05 | 2 | 225 | 2 | 29968565 | |
| Pubmed | ID3 regulates the MDC1-mediated DNA damage response in order to maintain genome stability. | 4.17e-05 | 2 | 225 | 2 | 29026069 | |
| Pubmed | WNK Inhibition Increases Surface Liquid pH and Host Defense in Cystic Fibrosis Airway Epithelia. | 4.17e-05 | 2 | 225 | 2 | 35849656 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 12110693 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 27321892 | ||
| Pubmed | SETD2-mediated crosstalk between H3K36me3 and H3K79me2 in MLL-rearranged leukemia. | 4.17e-05 | 2 | 225 | 2 | 29249820 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 20332206 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 7731705 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 38072993 | ||
| Pubmed | Set1 and MLL1/2 Target Distinct Sets of Functionally Different Genomic Loci In Vivo. | 4.17e-05 | 2 | 225 | 2 | 26711341 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 17360660 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 18384750 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 27615679 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 34877804 | ||
| Pubmed | Synaptic activity controls localization and function of CtBP1 via binding to Bassoon and Piccolo. | 4.17e-05 | 2 | 225 | 2 | 25652077 | |
| Pubmed | KMT2A and KMT2B Mediate Memory Function by Affecting Distinct Genomic Regions. | 4.17e-05 | 2 | 225 | 2 | 28723559 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 25961504 | ||
| Pubmed | Cardiac myosin binding protein-C plays no regulatory role in skeletal muscle structure and function. | 4.17e-05 | 2 | 225 | 2 | 23936073 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 18065500 | ||
| Pubmed | Comparison of methylation episignatures in KMT2B- and KMT2D-related human disorders. | 4.17e-05 | 2 | 225 | 2 | 35506254 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 32493491 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | REPS1 ACACB LSG1 DHX38 WNK1 ADD1 ZNF512B CEP170 GSE1 KMT2A HELZ PIH1D1 USP36 SPAG5 SETD2 BAZ2A PAK2 SCIN | 4.20e-05 | 934 | 225 | 18 | 33916271 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | AMER1 USP9X WNK1 ADD1 RUSC2 CEP170 GNAS DMD PIH1D1 TOM1L2 NEDD4L POLR2I LPIN3 SETD2 SHROOM1 ARRB2 WDCP PRKAR1B WDTC1 | 5.11e-05 | 1038 | 225 | 19 | 26673895 |
| Pubmed | 5.81e-05 | 103 | 225 | 6 | 10574462 | ||
| Pubmed | ASXL1 KMT2B ACACB USP9X ETV6 GON4L RREB1 TCEAL1 PRDM1 ZNF512B GSE1 KMT2A HELZ TADA2A HOMEZ ATN1 MSL1 ZMIZ1 KMT2D WDCP MDC1 AUTS2 SLX4 | 5.98e-05 | 1429 | 225 | 23 | 35140242 | |
| Pubmed | ARHGAP24 HDAC4 LSG1 USP9X SIPA1L3 APC2 ANKS1B ADD1 LUZP1 CEP170 BSN WNK2 KIF13B NEDD4L WDR47 DCHS1 PAK2 PRKAR1B | 6.21e-05 | 963 | 225 | 18 | 28671696 | |
| Pubmed | 7.02e-05 | 209 | 225 | 8 | 36779422 | ||
| Pubmed | The transcriptional repressor Blimp1/PRDM1 regulates the maternal decidual response in mice. | 7.28e-05 | 13 | 225 | 3 | 32493987 | |
| Pubmed | 7.28e-05 | 13 | 225 | 3 | 32332736 | ||
| Pubmed | Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library. | 9.23e-05 | 14 | 225 | 3 | 17662146 | |
| Pubmed | 1.13e-04 | 116 | 225 | 6 | 21102463 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SETX KMT2B MBD1 DHX38 RREB1 ITPR3 ZNF512B PWWP2A KMT2A TADA2A HOMEZ USP36 ABCC1 POLR2I MSL1 SETD2 KMT2D BAZ2A CDK13 MDC1 ANKRD11 | 1.13e-04 | 1294 | 225 | 21 | 30804502 |
| Pubmed | 1.15e-04 | 15 | 225 | 3 | 16510875 | ||
| Pubmed | 1.15e-04 | 15 | 225 | 3 | 25458012 | ||
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 1.21e-04 | 289 | 225 | 9 | 23752268 | |
| Pubmed | Absence of GNAS and BRAF mutations but presence of KRAS mutation in urachal adenocarcinoma. | 1.24e-04 | 3 | 225 | 2 | 28285720 | |
| Pubmed | WNK1 activates SGK1 to regulate the epithelial sodium channel. | 1.24e-04 | 3 | 225 | 2 | 16006511 | |
| Pubmed | Ca2+-dependent proteolysis of junctophilin-1 and junctophilin-2 in skeletal and cardiac muscle. | 1.24e-04 | 3 | 225 | 2 | 23148318 | |
| Interaction | YWHAH interactions | TNK1 AMER1 EPPK1 SETX HDAC4 LSG1 SIPA1L3 DHX38 ARHGEF17 WNK1 LUZP1 RUSC2 CEP170 KCNQ5 BRAF STARD9 KMT2A PACS2 HECTD1 WNK2 ARAP2 HOMEZ KIF13B NEDD4L ARHGEF5 LPIN3 SHROOM1 ARRB2 ANKRD11 PAK2 FMN2 AKAP11 MAST3 | 1.05e-07 | 1102 | 218 | 33 | int:YWHAH |
| Interaction | YWHAG interactions | TNK1 AMER1 HDAC4 SIPA1L3 MBD1 ARHGEF17 WNK1 LUZP1 RUSC2 CEP170 CFD KCNQ5 BRAF STARD9 KMT2A PACS2 HELZ GNAS PIH1D1 HECTD1 ARAP2 HOMEZ KIF13B NEDD4L ARHGEF5 LPIN3 SHROOM1 ARRB2 ANKRD11 PAK2 FMN2 TNK2 AKAP11 MAST3 | 5.98e-07 | 1248 | 218 | 34 | int:YWHAG |
| Interaction | KAT8 interactions | 9.03e-07 | 95 | 218 | 9 | int:KAT8 | |
| Interaction | SFN interactions | TNK1 HDAC4 SIPA1L3 ARHGEF17 WNK1 LUZP1 RUSC2 CEP170 KCNQ5 BRAF KMT2A PACS2 PIH1D1 HECTD1 ARAP2 KIF13B NEDD4L ARHGEF5 PAK2 FMN2 AKAP11 | 2.15e-05 | 692 | 218 | 21 | int:SFN |
| Interaction | KAT14 interactions | 2.99e-05 | 112 | 218 | 8 | int:KAT14 | |
| Interaction | SH3RF3 interactions | 3.09e-05 | 56 | 218 | 6 | int:SH3RF3 | |
| Interaction | YY1 interactions | ASXL1 KMT2B HDAC4 GON4L ZNF512B CFD KMT2A TADA2A NEDD4L MSL1 CEP164 PIAS4 MDC1 CYSRT1 SLX4 SMAD3 | 3.73e-05 | 454 | 218 | 16 | int:YY1 |
| Interaction | YWHAZ interactions | TNK1 ASXL1 HDAC4 SIPA1L3 WNK1 LUZP1 RUSC2 CEP170 CFD KCNQ5 BRAF STARD9 KMT2A PACS2 PIH1D1 HECTD1 WNK2 ARAP2 HOMEZ KIF13B NEDD4L ARHGEF5 SPAG5 LPIN3 CSF2RB IGHA2 MDC1 PAK2 TNK2 AKAP11 MAST3 | 3.74e-05 | 1319 | 218 | 31 | int:YWHAZ |
| Interaction | YWHAB interactions | TNK1 HDAC4 SIPA1L3 ARHGEF17 WNK1 LUZP1 RUSC2 CEP170 CFD KCNQ5 BRAF STARD9 KMT2A PACS2 HECTD1 ARAP2 HOMEZ KIF13B NEDD4L ARHGEF5 LPIN3 SHROOM1 ARRB2 PAK2 AKAP11 MAST3 | 4.06e-05 | 1014 | 218 | 26 | int:YWHAB |
| Cytoband | Xp21.1 | 2.32e-05 | 34 | 225 | 4 | Xp21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp21 | 6.09e-05 | 84 | 225 | 5 | chrXp21 | |
| Cytoband | 9q21.32 | 1.06e-04 | 19 | 225 | 3 | 9q21.32 | |
| Cytoband | 19p13.11 | 4.69e-04 | 73 | 225 | 4 | 19p13.11 | |
| Cytoband | 2q37.3 | 5.74e-04 | 77 | 225 | 4 | 2q37.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 6.57e-04 | 8 | 225 | 2 | chr9q12 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.41e-06 | 34 | 137 | 5 | 487 | |
| GeneFamily | Zinc fingers CXXC-type | 8.91e-05 | 12 | 137 | 3 | 136 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.43e-04 | 66 | 137 | 5 | 722 | |
| GeneFamily | PHD finger proteins | 6.09e-04 | 90 | 137 | 5 | 88 | |
| GeneFamily | Zinc fingers MIZ-type | 1.17e-03 | 7 | 137 | 2 | 85 | |
| GeneFamily | Fibronectin type III domain containing | 1.39e-03 | 160 | 137 | 6 | 555 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 1.55e-03 | 8 | 137 | 2 | 658 | |
| GeneFamily | UPF1 like RNA helicases | 3.00e-03 | 11 | 137 | 2 | 1169 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 3.00e-03 | 11 | 137 | 2 | 1025 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | BOC TRABD2B ACACB CILP2 MN1 SIM2 KIAA1614 WDR47 SLC25A12 SMAD3 | 2.62e-08 | 178 | 225 | 10 | a55130670aa95a87b833dd3cd2de461d779e4c06 |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | TRABD2B SSC5D CILP2 GLI1 PEAR1 KIF13B ISLR2 SHROOM1 PTCH2 MMRN2 | 4.39e-08 | 188 | 225 | 10 | c90669b51e1902fe7726555290c91c92a911df83 |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | TRABD2B ACACB TBC1D2 ARHGEF17 NACAD RUSC2 ZNF469 KIAA1614 CSF1 SMAD3 | 6.20e-08 | 195 | 225 | 10 | 5562665dd3beb70e2358aa32611a337bef5731c1 |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.08e-07 | 183 | 225 | 9 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.35e-07 | 189 | 225 | 9 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 5.59e-07 | 190 | 225 | 9 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | droplet-Fat-Bat|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-06 | 170 | 225 | 8 | c4ecdfc2b4710da0a5fbb20e9df02536023badb1 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.52e-06 | 170 | 225 | 8 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | droplet-Fat-Bat-18m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-06 | 170 | 225 | 8 | c720d81bc29a8fd1f1249c6af408471d561f1d5d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Cilia-bearing_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.87e-06 | 173 | 225 | 8 | d4cbeae262abfa30d8c5452285d3261a96875610 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.41e-06 | 177 | 225 | 8 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-06 | 178 | 225 | 8 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.02e-06 | 181 | 225 | 8 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | VE-CD4-CD4_Treg|VE / Condition, Cell_class and T cell subcluster | 4.25e-06 | 129 | 225 | 7 | e89d414e1b23e1656747defa39f09b51944a2166 | |
| ToppCell | wk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.54e-06 | 184 | 225 | 8 | eac2a9089913f33a961ba11519b53645790f2056 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.54e-06 | 184 | 225 | 8 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.54e-06 | 184 | 225 | 8 | 590fb32bb1f348ea5fa2aece30ebe1e212512991 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.72e-06 | 185 | 225 | 8 | 7b1c5d99bd7a6e148524029758cee244a17f5d09 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.72e-06 | 185 | 225 | 8 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.72e-06 | 185 | 225 | 8 | e9033a03d574956cf3ae228740b3166e40a6397f | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.72e-06 | 185 | 225 | 8 | 578f12c6b2e33d09598dc8e022a20c8555d1325c | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 5.31e-06 | 188 | 225 | 8 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.53e-06 | 189 | 225 | 8 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 6.44e-06 | 193 | 225 | 8 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 6.69e-06 | 194 | 225 | 8 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.28e-06 | 140 | 225 | 7 | af9efcbaeeae69fcdac4a15fa244728b65915564 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 8.36e-06 | 200 | 225 | 8 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | (2)_NK/T-(23)_CD4+_T_cell-(230)_CD4+/CD25+_Reg_T_cell|(23)_CD4+_T_cell / immune cells in Peripheral Blood (logTPM normalization) | 1.36e-05 | 154 | 225 | 7 | 059bdf6843f94f5028d4df6aa025865a9edb4521 | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-maDC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.74e-05 | 160 | 225 | 7 | 7db30647b596f0c419087e6fabb9b99dcd5bddd4 | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.74e-05 | 160 | 225 | 7 | 01f22cdb2a2f73776b7f91746e95c1850df94235 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.81e-05 | 161 | 225 | 7 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.96e-05 | 163 | 225 | 7 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-05 | 164 | 225 | 7 | b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-05 | 165 | 225 | 7 | 62457b7b74c6eae42d91d65e7dc6df6bf8e061f7 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 166 | 225 | 7 | 829a8998ce68739a58202851afd73e049ab0f84f | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 166 | 225 | 7 | c43aec09578975df8984886993d15b42a10190c8 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-05 | 169 | 225 | 7 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 172 | 225 | 7 | 10a1d1838492b8ce6dea08844353b51571432c56 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-05 | 172 | 225 | 7 | eb199c279fe8a2551121db37e9556893197d33ff | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 172 | 225 | 7 | d824e46c8040b0bb9235f9b8a2b35386b303caa0 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-05 | 172 | 225 | 7 | 709c6b77a7a52b873eefb6caca28a41291d384af | |
| ToppCell | facs-MAT-Fat-18m-Lymphocytic-T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 173 | 225 | 7 | 97391a763c17ce0107c9e2386e88c417ac75a72e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-05 | 180 | 225 | 7 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.83e-05 | 181 | 225 | 7 | fc51468c74534b60b4e786bd512d0f1c5dc05de7 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-05 | 181 | 225 | 7 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-05 | 181 | 225 | 7 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-05 | 182 | 225 | 7 | 587636c0f127231de21acd8aa632b74ff22ca8c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-05 | 182 | 225 | 7 | adfadd7893e74b3002f13f00875e3667d3493e0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-05 | 182 | 225 | 7 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.97e-05 | 182 | 225 | 7 | 03a5a02acd48f0eb210485348bfe0cd21f486215 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.97e-05 | 182 | 225 | 7 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.37e-05 | 126 | 225 | 6 | 10e1448a03f79965b72922fd83ef51de1b7b474f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.40e-05 | 185 | 225 | 7 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | Control-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 4.40e-05 | 185 | 225 | 7 | 6814b3c94c7558443c038a227b5c8563d2cfeac4 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.40e-05 | 185 | 225 | 7 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.40e-05 | 185 | 225 | 7 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-05 | 186 | 225 | 7 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-05 | 186 | 225 | 7 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.55e-05 | 186 | 225 | 7 | 827f2f2ddde315d1e5970dd56f906c555ec699af | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 4.71e-05 | 187 | 225 | 7 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | COVID-19-kidney-CD-IC-B|kidney / Disease (COVID-19 only), tissue and cell type | 4.71e-05 | 187 | 225 | 7 | ce05b89860573fe0356102e2998d1ef6d1968034 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-05 | 188 | 225 | 7 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 4.87e-05 | 188 | 225 | 7 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.87e-05 | 188 | 225 | 7 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.04e-05 | 189 | 225 | 7 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.04e-05 | 189 | 225 | 7 | da9ecc0d7b81c1901f30f97bb44112dc85444a66 | |
| ToppCell | CTRL-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 5.04e-05 | 189 | 225 | 7 | 14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 5.04e-05 | 189 | 225 | 7 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 5.21e-05 | 190 | 225 | 7 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3-Excitatory_Neuron.Slc17a7.Pvrl3-Fos_(CA3_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.30e-05 | 80 | 225 | 5 | b661644806e225f215047e78ae46d7cee6efde4f | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-05 | 191 | 225 | 7 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.39e-05 | 191 | 225 | 7 | 273c4a757292a9301de0eaeacdec91c9866be229 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-05 | 191 | 225 | 7 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-05 | 191 | 225 | 7 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.39e-05 | 191 | 225 | 7 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 5.39e-05 | 191 | 225 | 7 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.39e-05 | 191 | 225 | 7 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.39e-05 | 191 | 225 | 7 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-05 | 191 | 225 | 7 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-05 | 192 | 225 | 7 | d525f7f088a53110912600a7c9f6d33b9270d534 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-05 | 192 | 225 | 7 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-05 | 192 | 225 | 7 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-05 | 192 | 225 | 7 | 2bfac6b3956265205ca47d06888851ed68b65999 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-05 | 192 | 225 | 7 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-05 | 192 | 225 | 7 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.75e-05 | 193 | 225 | 7 | 194e7fa00a50cc4e026987b715323d125d79594e | |
| ToppCell | CF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 5.75e-05 | 193 | 225 | 7 | 7ebf20344a9a154fd2cffa281526867fcf0aded3 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.94e-05 | 194 | 225 | 7 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.14e-05 | 195 | 225 | 7 | a4d36654b968acb1aea252ac203683939461f1d1 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.14e-05 | 195 | 225 | 7 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.14e-05 | 195 | 225 | 7 | cd811abd949ef201aef1c8515da5575ab1b1cfea | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.34e-05 | 196 | 225 | 7 | a58bdf9de05d13d84211e09a933679d485bf8ab4 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 6.34e-05 | 196 | 225 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.54e-05 | 197 | 225 | 7 | e239caae24f40564a24ad909754f5436f767ccdb | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.75e-05 | 198 | 225 | 7 | 62059185afdf66126a6fbc899ce611c47e7a0feb | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.97e-05 | 199 | 225 | 7 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.97e-05 | 199 | 225 | 7 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.97e-05 | 199 | 225 | 7 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.97e-05 | 199 | 225 | 7 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.97e-05 | 199 | 225 | 7 | c1760581c34b81d1d92c67500a1c8944e9cc6dad | |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | ASXL1 ACACB SIPA1L3 CDC42EP2 TADA2A KIF13B ZNF473 PIAS4 ACBD4 BAZ2A SMAD3 WDTC1 | 3.84e-07 | 196 | 215 | 12 | 3183_DN |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | TBC1D2 ARHGEF17 WNK1 GNAS MMP17 ATN1 SIM2 CEP164 CEMIP ACBD4 MAST3 WDTC1 | 4.06e-07 | 197 | 215 | 12 | 3885_DN |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | INPP5B SIPA1L3 PTPN22 ARHGEF17 GNAS MMP17 ZNF473 ZDHHC14 PRKAR1B INPP5J SMAD3 WDTC1 | 4.06e-07 | 197 | 215 | 12 | 3618_DN |
| Drug | Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; MCF7; HT_HG-U133A | WNK1 MAP3K12 RUSC2 SEMA6D HELZ TADA2A ABCC1 BAHD1 CEP164 CSF1 BAZ2A WDTC1 | 4.52e-07 | 199 | 215 | 12 | 3543_DN |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | EPPK1 HDAC4 INPP5B MAP3K12 CFD IQCE USP36 ATN1 IER2 PIGQ SMAD3 | 2.38e-06 | 193 | 215 | 11 | 5566_DN |
| Drug | Aztreonam [78110-38-0]; Down 200; 9.2uM; PC3; HT_HG-U133A | SETX ACACB MBD1 GON4L WNK1 RUSC2 BRAF GNAS SNAPC4 MAST3 WDTC1 | 2.51e-06 | 194 | 215 | 11 | 2118_DN |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 1uM; PC3; HT_HG-U133A | TNK1 ACACB SIPA1L3 TBC1D2 MAP3K12 RUSC2 ANKRD2 GNAS CSF1 CDK13 WDTC1 | 2.64e-06 | 195 | 215 | 11 | 3735_DN |
| Drug | Acebutolol hydrochloride [34381-68-5]; Up 200; 10.8uM; MCF7; HT_HG-U133A | INPP5B MBD1 RUSC2 SEMA6D ANKRD2 GNAS IQCE CEMIP BAZ2A PRKAR1B SMAD3 | 3.05e-06 | 198 | 215 | 11 | 1493_UP |
| Drug | Palmatine chloride [3486-67-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A | ACACB EFS TBC1D2 ARHGEF17 PGR SEMA6D BAZ2A CCDC87 PRKAR1B TNK2 SMAD3 | 3.21e-06 | 199 | 215 | 11 | 4957_UP |
| Drug | Astemizole [68844-77-9]; Down 200; 8.8uM; PC3; HT_HG-U133A | ARHGAP24 ACACB INPP5B SIPA1L3 LUZP1 KMT2A WDCP PRKAR1B SMAD3 WDTC1 | 1.45e-05 | 191 | 215 | 10 | 4471_DN |
| Drug | Indomethacin [53-86-1]; Up 200; 11.2uM; HL60; HT_HG-U133A | KMT2B ACACB EFS SIPA1L3 ITPR3 SIM2 CEP164 ARRB2 SMAD3 ZNF646 | 1.66e-05 | 194 | 215 | 10 | 2377_UP |
| Drug | ionomycin calcium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA | SETX NAA80 PTPN22 MAP3K12 PGR ATN1 SIM2 KMT2D HERPUD1 INPP5J | 1.74e-05 | 195 | 215 | 10 | 871_UP |
| Drug | Indapamide [26807-65-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | INPP5B SIPA1L3 ARHGEF17 RUSC2 SEMA6D ANKRD2 TADA2A CEMIP CSF1 BAZ2A | 1.82e-05 | 196 | 215 | 10 | 3970_DN |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 1uM; MCF7; HT_HG-U133A | GON4L MAP3K12 LUZP1 IQCE ZDHHC14 CEMIP CSF1 BAZ2A PRKAR1B WDTC1 | 1.82e-05 | 196 | 215 | 10 | 3857_DN |
| Drug | Suxibuzone [27470-51-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | PRRG1 ACACB PTPN22 SEMA6D CDC42EP2 GNAS WDCP AUTS2 PRKAR1B INPP5J | 1.82e-05 | 196 | 215 | 10 | 6065_DN |
| Drug | Benfotiamine [22457-89-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.82e-05 | 196 | 215 | 10 | 3837_UP | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; HL60; HG-U133A | 1.90e-05 | 197 | 215 | 10 | 1975_DN | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A | SIPA1L3 LUZP1 MMP17 KIF13B CEP164 CSF1 CDK13 TNK2 INPP5J WDTC1 | 1.90e-05 | 197 | 215 | 10 | 3886_DN |
| Drug | Sulfanilamide [63-74-1]; Down 200; 23.2uM; PC3; HT_HG-U133A | SIPA1L3 NAA80 WNK1 IQCE CEP164 CEMIP BAZ2A PRKAR1B SNAPC4 WDTC1 | 1.90e-05 | 197 | 215 | 10 | 4474_DN |
| Drug | Diazoxide [364-98-7]; Down 200; 17.4uM; PC3; HT_HG-U133A | ACACB C11orf24 MAP3K12 RUSC2 GSE1 BAHD1 CSF1 MCM9 TNK2 MAST3 | 1.90e-05 | 197 | 215 | 10 | 5810_DN |
| Drug | Skimmianine [83-95-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | ARHGAP24 GON4L HELZ TADA2A NEDD4L ZNF473 CSF1 CDK13 SNAPC4 MAST3 | 1.90e-05 | 197 | 215 | 10 | 5766_DN |
| Drug | Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.90e-05 | 197 | 215 | 10 | 5703_UP | |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; MCF7; HT_HG-U133A | SIPA1L3 NAA80 PGR PRDM1 BTN3A3 SEMA6D PRUNE2 ATN1 SIM2 ADAMTS7 | 1.98e-05 | 198 | 215 | 10 | 2281_UP |
| Drug | Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A | INPP5B LUZP1 RUSC2 SEMA6D GNAS CEP164 PIAS4 SETD2 INPP5J WDTC1 | 1.98e-05 | 198 | 215 | 10 | 6080_DN |
| Drug | rotenone; Down 200; 1uM; MCF7; HT_HG-U133A | 1.98e-05 | 198 | 215 | 10 | 5915_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | EPPK1 SETX SETD1B INPP5B SIPA1L3 BAHD1 WDCP OAZ3 SMAD3 WDTC1 | 1.98e-05 | 198 | 215 | 10 | 5335_DN |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; PC3; HT_HG-U133A | ARHGAP24 ACACB GON4L WNK1 ANKRD2 PIGQ ARRB2 BAZ2A DNAH17 INPP5J | 2.07e-05 | 199 | 215 | 10 | 6349_UP |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | SETD1B INPP5B GON4L LUZP1 KIF13B ATN1 SIM2 PIGQ PRKAR1B WDTC1 | 2.07e-05 | 199 | 215 | 10 | 5570_DN |
| Drug | Furazolidone [67-45-8]; Down 200; 17.8uM; PC3; HT_HG-U133A | 2.07e-05 | 199 | 215 | 10 | 4098_DN | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A | FOXN3 ARHGEF17 RUSC2 SEMA6D TADA2A ZNF473 ADAMTS7 CCDC87 PRKAR1B MYBPC3 | 2.16e-05 | 200 | 215 | 10 | 6450_UP |
| Drug | Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; PC3; HT_HG-U133A | TNK1 EPPK1 INPP5B ADD1 BTN3A3 BRAF ZNF473 ZDHHC14 WDCP MAST3 | 2.16e-05 | 200 | 215 | 10 | 5842_DN |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 6.63e-05 | 184 | 215 | 9 | 4430_DN | |
| Drug | cyclopamine | 7.17e-05 | 46 | 215 | 5 | ctd:C000541 | |
| Drug | genistein; Down 200; 10uM; HL60; HT_HG-U133A | ASXL1 ZNF142 SIPA1L3 MAP3K12 ZNF512B GSE1 BAZ2A SNAPC4 MAST3 | 7.82e-05 | 188 | 215 | 9 | 1176_DN |
| Drug | Boc-NLP | 8.88e-05 | 2 | 215 | 2 | CID003018728 | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 9.19e-05 | 192 | 215 | 9 | 4104_DN | |
| Drug | 5155877; Up 200; 10uM; PC3; HT_HG-U133A | 9.19e-05 | 192 | 215 | 9 | 6544_UP | |
| Drug | Fenbufen [36330-85-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 9.56e-05 | 193 | 215 | 9 | 4743_UP | |
| Drug | Antimycin A [1397-94-0]; Down 200; 7.2uM; PC3; HT_HG-U133A | 9.56e-05 | 193 | 215 | 9 | 2098_DN | |
| Drug | semustine; Up 200; 100uM; PC3; HT_HG-U133A | IL15RA MAP3K12 TADA2A BAZ2A DNAH17 SNAPC4 SCIN HERPUD1 WDTC1 | 9.94e-05 | 194 | 215 | 9 | 7492_UP |
| Drug | Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 1.03e-04 | 195 | 215 | 9 | 3525_DN | |
| Drug | Metolazone [17560-51-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.03e-04 | 195 | 215 | 9 | 1514_DN | |
| Drug | Butamben [94-25-7]; Down 200; 20.6uM; MCF7; HT_HG-U133A | 1.03e-04 | 195 | 215 | 9 | 6266_DN | |
| Drug | Amoxicillin [26787-78-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.03e-04 | 195 | 215 | 9 | 5385_UP | |
| Drug | Tiabendazole [148-79-8]; Up 200; 19.8uM; MCF7; HT_HG-U133A | 1.03e-04 | 195 | 215 | 9 | 4402_UP | |
| Drug | Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.03e-04 | 195 | 215 | 9 | 4019_DN | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 1.03e-04 | 195 | 215 | 9 | 1505_DN | |
| Drug | Glipizide [29094-61-9]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.03e-04 | 195 | 215 | 9 | 4991_UP | |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.03e-04 | 195 | 215 | 9 | 3834_UP | |
| Drug | AH23848 hemicalcium salt hydrate; Down 200; 1uM; MCF7; HT_HG-U133A | 1.03e-04 | 195 | 215 | 9 | 6890_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.08e-04 | 196 | 215 | 9 | 3872_DN | |
| Drug | Atractyloside potassium salt [102130-43-8]; Up 200; 5uM; MCF7; HT_HG-U133A | 1.08e-04 | 196 | 215 | 9 | 3435_UP | |
| Drug | Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.08e-04 | 196 | 215 | 9 | 5088_UP | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.08e-04 | 196 | 215 | 9 | 1684_DN | |
| Drug | Liothyronine [6893-02-3]; Down 200; 6.2uM; PC3; HT_HG-U133A | 1.08e-04 | 196 | 215 | 9 | 6602_DN | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 1.08e-04 | 196 | 215 | 9 | 4826_DN | |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; PC3; HG-U133A | 1.08e-04 | 196 | 215 | 9 | 1912_UP | |
| Drug | Glibenclamide [10238-21-8]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.12e-04 | 197 | 215 | 9 | 7202_DN | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.12e-04 | 197 | 215 | 9 | 5436_DN | |
| Drug | Quipazine dimaleate salt [4774-24-7]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.12e-04 | 197 | 215 | 9 | 2782_UP | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Up 200; 13.4uM; MCF7; HT_HG-U133A | IL15RA NAA80 FOXN3 WNK1 CDC42EP2 USP36 ZDHHC14 PRKAR1B MAST3 | 1.12e-04 | 197 | 215 | 9 | 3447_UP |
| Drug | Naloxone hydrochloride [357-08-4]; Up 200; 11uM; MCF7; HT_HG-U133A | ACACB EFS TBC1D2 ARHGEF17 ZNF473 ZDHHC14 CEP164 CSF2RB AUTS2 | 1.12e-04 | 197 | 215 | 9 | 1506_UP |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; MCF7; HT_HG-U133A | NAA80 ARHGEF17 MAP3K12 ANKRD2 TADA2A ZDHHC14 BAZ2A SNAPC4 MAST3 | 1.12e-04 | 197 | 215 | 9 | 5009_UP |
| Drug | Lisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.12e-04 | 197 | 215 | 9 | 1545_DN | |
| Drug | Iopamidol [60166-93-0]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 1.12e-04 | 197 | 215 | 9 | 3473_DN | |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.12e-04 | 197 | 215 | 9 | 6100_DN | |
| Drug | Pirenperone [ 75444-65-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.12e-04 | 197 | 215 | 9 | 3316_UP | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; PC3; HT_HG-U133A | 1.12e-04 | 197 | 215 | 9 | 5865_DN | |
| Drug | Sulfameter [651-06-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.12e-04 | 197 | 215 | 9 | 6212_DN | |
| Drug | Acetohexamide [968-81-0]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.12e-04 | 197 | 215 | 9 | 1707_UP | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.16e-04 | 198 | 215 | 9 | 4762_DN | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | FOXN3 ARHGEF17 MAP3K12 KMT2A TADA2A USP36 SETD2 PRKAR1B SMAD3 | 1.16e-04 | 198 | 215 | 9 | 4729_DN |
| Drug | Flavoxate hydrochloride [3717-88-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.16e-04 | 198 | 215 | 9 | 5427_UP | |
| Drug | Enalapril maleate [76095-16-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 1.16e-04 | 198 | 215 | 9 | 7428_UP | |
| Drug | Sulfapyridine [144-83-2]; Down 200; 16uM; HL60; HT_HG-U133A | SIPA1L3 C11orf24 FOXN3 RUSC2 TADA2A ZDHHC14 CDK13 KAT6B WDTC1 | 1.16e-04 | 198 | 215 | 9 | 2538_DN |
| Drug | Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; PC3; HG-U133A | 1.21e-04 | 199 | 215 | 9 | 1888_UP | |
| Drug | (-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.21e-04 | 199 | 215 | 9 | 6458_DN | |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HG-U133A | 1.21e-04 | 199 | 215 | 9 | 315_UP | |
| Drug | Ethoxyquin [91-53-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 1.21e-04 | 199 | 215 | 9 | 3421_UP | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A | ASXL1 IL15RA ZNF512B BRAF CDC42EP2 ABCC1 SLC25A12 CDK13 MAST3 | 1.21e-04 | 199 | 215 | 9 | 7233_DN |
| Drug | Clopamide [636-54-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.21e-04 | 199 | 215 | 9 | 3220_UP | |
| Drug | Terazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.21e-04 | 199 | 215 | 9 | 6092_DN | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.25e-04 | 200 | 215 | 9 | 4789_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; PC3; HG-U133A | 1.25e-04 | 200 | 215 | 9 | 665_DN | |
| Drug | Gabapentin [60142-96-3]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 1.25e-04 | 200 | 215 | 9 | 7229_DN | |
| Disease | Colorectal Carcinoma | BOC CPAMD8 EFS APC2 OBSCN WNK1 AXIN2 MYLK3 KCNQ5 GSE1 BRAF SESN2 GNAS DMD ABCC1 ZMIZ1 DCHS1 MMRN2 SPAG17 SMAD3 | 1.70e-07 | 702 | 210 | 20 | C0009402 |
| Disease | Malignant neoplasm of breast | BOC PRRG1 HDAC4 APC2 OBSCN WNK1 PGR FCRL3 BRAF GLI1 DMD SPOCD1 TREML1 DNAH9 ABCC1 WDR88 ZMIZ1 SETD2 KMT2D CSF1 WDCP KAT6B ZNF646 | 2.81e-06 | 1074 | 210 | 23 | C0006142 |
| Disease | Global developmental delay | 5.27e-06 | 133 | 210 | 8 | C0557874 | |
| Disease | congenital heart disease (implicated_via_orthology) | 9.98e-06 | 69 | 210 | 6 | DOID:1682 (implicated_via_orthology) | |
| Disease | Gastrointestinal Stromal Tumors | 2.84e-05 | 50 | 210 | 5 | C0238198 | |
| Disease | Intellectual Disability | ZNF142 HDAC4 APC2 GON4L KCNQ5 ARL13B PACS2 GNAS MN1 ATN1 ZMIZ1 SETD2 | 9.48e-05 | 447 | 210 | 12 | C3714756 |
| Disease | smoking cessation | ASXL1 ANKS1B ITPR3 SEMA6D BSN ARAP2 TOM1L2 SHBG ADAMTS7 AUTS2 | 1.22e-04 | 325 | 210 | 10 | EFO_0004319 |
| Disease | Burkitt Lymphoma | 1.23e-04 | 36 | 210 | 4 | C0006413 | |
| Disease | HDL cholesterol change measurement, response to statin | 1.51e-04 | 3 | 210 | 2 | EFO_0007805, GO_0036273 | |
| Disease | rheumatoid arthritis, Crohn's disease | 1.52e-04 | 38 | 210 | 4 | EFO_0000384, EFO_0000685 | |
| Disease | Colorectal Neoplasms | 1.77e-04 | 277 | 210 | 9 | C0009404 | |
| Disease | Cardiovascular Abnormalities | 1.86e-04 | 16 | 210 | 3 | C0243050 | |
| Disease | Feeding difficulties | 2.68e-04 | 18 | 210 | 3 | C0232466 | |
| Disease | Brachydactyly | 3.00e-04 | 4 | 210 | 2 | C0221357 | |
| Disease | TYPE 1 DIABETES MELLITUS | 3.00e-04 | 4 | 210 | 2 | 222100 | |
| Disease | Diabetes mellitus type 1 | 3.00e-04 | 4 | 210 | 2 | cv:C0011854 | |
| Disease | Sotos' syndrome | 3.00e-04 | 4 | 210 | 2 | C0175695 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 3.32e-04 | 239 | 210 | 8 | EFO_0010934 | |
| Disease | carotid plaque build | 3.41e-04 | 84 | 210 | 5 | EFO_0006501 | |
| Disease | Gastrointestinal Stromal Sarcoma | 3.50e-04 | 47 | 210 | 4 | C3179349 | |
| Disease | sexual dimorphism measurement | ZNF142 EPPK1 KMT2B INPP5B ETV6 SSC5D BSN SPOCD1 USP36 SHBG SPATA31C2 MSL1 ZMIZ1 CEP164 ANKRD11 HERPUD1 NPAS4 SMAD3 MYBPC3 | 3.77e-04 | 1106 | 210 | 19 | EFO_0021796 |
| Disease | Precursor B-cell lymphoblastic leukemia | 4.30e-04 | 21 | 210 | 3 | C1292769 | |
| Disease | Abnormality of the cerebellum | 4.97e-04 | 5 | 210 | 2 | C1866129 | |
| Disease | Malignant Cystosarcoma Phyllodes | 4.97e-04 | 5 | 210 | 2 | C0600066 | |
| Disease | Phyllodes Tumor | 4.97e-04 | 5 | 210 | 2 | C0010701 | |
| Disease | body weight | NEXMIF INPP5B MBD1 ANKS1B ETV6 GON4L DCST2 APOBR AXIN2 SEMA6D KCNQ5 GSE1 GNAS DMD HOMEZ SPATA31C2 SETD2 DACH2 AUTS2 KAT6B | 7.23e-04 | 1261 | 210 | 20 | EFO_0004338 |
| Disease | endometriosis (is_implicated_in) | 7.42e-04 | 6 | 210 | 2 | DOID:289 (is_implicated_in) | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 7.42e-04 | 6 | 210 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, multiple sclerosis | 7.42e-04 | 6 | 210 | 2 | EFO_0004611, MONDO_0005301 | |
| Disease | serum gamma-glutamyl transferase measurement | REPS1 SIPA1L3 GON4L RREB1 SEMA6D GSE1 KMT2A CCDC97 MMP17 ARAP2 IQCH NEDD4L ZMIZ1 SETD2 ZNF827 MAST3 | 9.00e-04 | 914 | 210 | 16 | EFO_0004532 |
| Disease | response to 5-fluorouracil, response to antineoplastic agent | 1.03e-03 | 7 | 210 | 2 | GO_0036275, GO_0097327 | |
| Disease | antipsychotic drug use measurement | 1.13e-03 | 29 | 210 | 3 | EFO_0007792 | |
| Disease | monocyte count | ASXL1 ZNF777 INPP5B GON4L PTPN22 RREB1 WNK1 CILP2 GSE1 TADA2A MN1 BCL2L13 PEAR1 TOM1L2 ZMIZ1 KIAA1614 SETD2 CSF1 PAK2 MYBPC3 | 1.26e-03 | 1320 | 210 | 20 | EFO_0005091 |
| Disease | platelet crit | RREB1 APOBR NCAPG2 PWWP2A GSE1 TADA2A MN1 JPH2 KIAA1614 LPIN3 CSF1 CDK13 DCHS1 PAK2 FMN2 UBALD1 | 1.37e-03 | 952 | 210 | 16 | EFO_0007985 |
| Disease | Abnormality of the skeletal system | 1.37e-03 | 8 | 210 | 2 | C4021790 | |
| Disease | myelofibrosis (is_implicated_in) | 1.37e-03 | 8 | 210 | 2 | DOID:4971 (is_implicated_in) | |
| Disease | Embryonal Rhabdomyosarcoma | 1.37e-03 | 8 | 210 | 2 | C0206656 | |
| Disease | tumor necrosis factor receptor superfamily member 19L measurement | 1.37e-03 | 8 | 210 | 2 | EFO_0008309 | |
| Disease | hair colour measurement | ASXL1 ARHGAP24 HDAC4 AXIN2 ZNF469 SEMA6D SHC4 MSL1 ZMIZ1 KMT2D ANKRD11 FMN2 | 1.61e-03 | 615 | 210 | 12 | EFO_0007822 |
| Disease | hyperuricemia | 1.66e-03 | 33 | 210 | 3 | EFO_0009104 | |
| Disease | synaptotagmin-11 measurement | 1.76e-03 | 9 | 210 | 2 | EFO_0802108 | |
| Disease | Graves Disease | 1.76e-03 | 9 | 210 | 2 | C0018213 | |
| Disease | colorectal cancer (is_implicated_in) | 1.77e-03 | 121 | 210 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 1.94e-03 | 181 | 210 | 6 | DOID:684 (is_implicated_in) | |
| Disease | creatinine measurement | SIPA1L3 OBSCN RREB1 CILP2 PSORS1C1 MYBPHL CFAP70 GNAS BSN KIAA1614 CEMIP ADAMTS7 ANKRD11 TNK2 CYSRT1 SMAD3 | 2.14e-03 | 995 | 210 | 16 | EFO_0004518 |
| Disease | susceptibility to strep throat measurement | 2.14e-03 | 76 | 210 | 4 | EFO_0008408 | |
| Disease | thyroid gland papillary carcinoma (is_implicated_in) | 2.18e-03 | 10 | 210 | 2 | DOID:3969 (is_implicated_in) | |
| Disease | Pseudohypoaldosteronism, Type I | 2.18e-03 | 10 | 210 | 2 | C0268436 | |
| Disease | Pseudohypoaldosteronism | 2.18e-03 | 10 | 210 | 2 | C0033805 | |
| Disease | Hyperpotassemia and Hypertension, Familial | 2.18e-03 | 10 | 210 | 2 | C2713447 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Recessive | 2.18e-03 | 10 | 210 | 2 | C1449843 | |
| Disease | Pseudohypoaldosteronism, Type II | 2.18e-03 | 10 | 210 | 2 | C1449844 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Dominant | 2.18e-03 | 10 | 210 | 2 | C1449842 | |
| Disease | basophil count | RREB1 LY6G5B ZNF469 CILP2 GSE1 CDC42EP2 ABCC1 SETD2 CSF2RB PAK2 | 2.55e-03 | 483 | 210 | 10 | EFO_0005090 |
| Disease | Systemic lupus erythematosus | 2.66e-03 | 11 | 210 | 2 | cv:C0024141 | |
| Disease | endometrial carcinoma, endometriosis | 2.66e-03 | 11 | 210 | 2 | EFO_0001065, EFO_1001512 | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma | 2.69e-03 | 39 | 210 | 3 | EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354 | |
| Disease | Cleft Palate | 2.70e-03 | 81 | 210 | 4 | C0008925 | |
| Disease | diastolic blood pressure, systolic blood pressure | IL15RA HDAC4 MBD1 ADD1 ZNF512B PSORS1C1 JPH2 CEP164 CEMIP CSF1 MMRN2 SMAD3 | 3.24e-03 | 670 | 210 | 12 | EFO_0006335, EFO_0006336 |
| Disease | HbA1c measurement | CPAMD8 ACACB FOXN3 RREB1 BSN USP36 ABCC1 SHBG ZMIZ1 ADAMTS7 WDCP MYBPC3 | 3.44e-03 | 675 | 210 | 12 | EFO_0004541 |
| Disease | influenza A (H1N1) | 3.50e-03 | 87 | 210 | 4 | EFO_1001488 | |
| Disease | subiculum volume | 3.56e-03 | 43 | 210 | 3 | EFO_0009399 | |
| Disease | multiple sclerosis | CPAMD8 EPPK1 ETV6 FAM47B RREB1 FAM221B FCRL3 ZMIZ1 LPIN3 CSF2RB MYBPC3 | 3.71e-03 | 594 | 210 | 11 | MONDO_0005301 |
| Disease | ventricular enlargement measurement | 3.73e-03 | 13 | 210 | 2 | EFO_0010570 | |
| Disease | colon carcinoma (is_marker_for) | 3.73e-03 | 13 | 210 | 2 | DOID:1520 (is_marker_for) | |
| Disease | cortisol measurement, response to corticosteroid, response to synacthen | 3.73e-03 | 13 | 210 | 2 | EFO_0005843, EFO_0009175, GO_0031960 | |
| Disease | gallbladder cancer (is_implicated_in) | 3.73e-03 | 13 | 210 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | high grade glioma (implicated_via_orthology) | 3.80e-03 | 44 | 210 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | lymphocyte count | EPPK1 PTPN22 RREB1 ZNF469 CILP2 HELZ SESN2 TADA2A ABCC1 JPH2 ID3 ZMIZ1 SETD2 ARRB2 CSF1 CDK13 DNAH17 ANKRD11 AUTS2 PAK2 | 4.12e-03 | 1464 | 210 | 20 | EFO_0004587 |
| Disease | colorectal cancer | BOC ETV6 RREB1 WNK1 NACAD PRDM1 GNAS TOM1L2 ZMIZ1 FMN2 SMAD3 | 4.20e-03 | 604 | 210 | 11 | MONDO_0005575 |
| Disease | Neurodevelopmental Disorders | 4.44e-03 | 93 | 210 | 4 | C1535926 | |
| Disease | nasopharyngeal neoplasm | 4.60e-03 | 151 | 210 | 5 | EFO_0004252 | |
| Disease | mean fractional anisotropy measurement | 4.79e-03 | 95 | 210 | 4 | EFO_0008399 | |
| Disease | Cardiomyopathy, Dilated | 4.86e-03 | 48 | 210 | 3 | C0007193 | |
| Disease | Prostatic Neoplasms | MBD1 TBC1D2 BRAF KMT2A ARHGEF5 SHBG ID3 SETD2 KMT2D BAZ2A HERPUD1 | 4.86e-03 | 616 | 210 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | MBD1 TBC1D2 BRAF KMT2A ARHGEF5 SHBG ID3 SETD2 KMT2D BAZ2A HERPUD1 | 4.86e-03 | 616 | 210 | 11 | C0376358 |
| Disease | eosinophil count | PDCD1 LSG1 SIPA1L3 IRAK2 DCST2 WNK1 ZDHHC8 NACAD ITPR3 CILP2 GSE1 SESN2 MMP17 BCL2L13 SETD2 CSF2RB ANKRD11 PAK2 MAST3 SMAD3 | 4.92e-03 | 1488 | 210 | 20 | EFO_0004842 |
| Disease | amyotrophic lateral sclerosis, age at onset | 4.98e-03 | 15 | 210 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | Replication Error Phenotype | 4.98e-03 | 15 | 210 | 2 | C1721098 | |
| Disease | Microsatellite Instability | 4.98e-03 | 15 | 210 | 2 | C0920269 | |
| Disease | urate measurement | DHX38 GON4L C11orf24 RREB1 GLI1 SESN2 GNAS IQCE ZMIZ1 ARHGEF25 CEMIP ZNF827 FMN2 MAST3 | 5.08e-03 | 895 | 210 | 14 | EFO_0004531 |
| Disease | lung adenocarcinoma (is_implicated_in) | 5.15e-03 | 49 | 210 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | pulse pressure measurement | ARHGAP24 INPP5B MBD1 RREB1 LUZP1 CILP2 KCNQ5 PSORS1C1 HOMEZ USP36 IQCH SHBG JPH2 ARHGEF25 CEP164 ZNF827 ANKRD11 SMAD3 MYBPC3 | 5.18e-03 | 1392 | 210 | 19 | EFO_0005763 |
| Disease | prostate cancer (is_marker_for) | 5.28e-03 | 156 | 210 | 5 | DOID:10283 (is_marker_for) | |
| Disease | Cardiomyopathy, Familial Idiopathic | 5.45e-03 | 50 | 210 | 3 | C1449563 | |
| Disease | hippocampal volume | 5.58e-03 | 297 | 210 | 7 | EFO_0005035 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 5.95e-03 | 101 | 210 | 4 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | Benign neoplasm of stomach | 6.39e-03 | 17 | 210 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 6.39e-03 | 17 | 210 | 2 | C0496905 | |
| Disease | response to citalopram, antidepressant-induced dizziness, response to buspirone, response to antidepressant | 6.39e-03 | 17 | 210 | 2 | EFO_0006321, EFO_0006329, EFO_0006330, GO_0036276 | |
| Disease | Carcinoma in situ of stomach | 6.39e-03 | 17 | 210 | 2 | C0154060 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 6.39e-03 | 17 | 210 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | mean platelet volume | SETD1B APOBR ZNF512B PWWP2A GSE1 GNAS HOMEZ PEAR1 ZDHHC14 ZMIZ1 SETD2 BAZ2A MCM9 ANKRD11 MYBPC3 | 6.58e-03 | 1020 | 210 | 15 | EFO_0004584 |
| Disease | body surface area | ETV6 RREB1 WNK1 LUZP1 AXIN2 GNAS SPATA31C2 ZMIZ1 ANKRD11 AUTS2 SMAD3 | 6.63e-03 | 643 | 210 | 11 | EFO_0022196 |
| Disease | bone density | 6.88e-03 | 388 | 210 | 8 | EFO_0003923 | |
| Disease | waist-hip ratio | CPAMD8 DSCR4 C11orf24 DCST2 RREB1 WNK1 SSC5D GSE1 MN1 PRUNE2 IQCH SHBG ZMIZ1 CEMIP PIAS4 DNAH17 SMAD3 | 6.92e-03 | 1226 | 210 | 17 | EFO_0004343 |
| Disease | leukemia | 7.10e-03 | 55 | 210 | 3 | C0023418 | |
| Disease | Diffuse Large B-Cell Lymphoma | 7.10e-03 | 55 | 210 | 3 | C0079744 | |
| Disease | hair color | 7.11e-03 | 311 | 210 | 7 | EFO_0003924 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EALPEAPAPLLPHIT | 336 | Q9BXK5 | |
| DPRPQAAEPPDHLTI | 1386 | Q5SW79 | |
| PIPQPFRPADEDHRN | 341 | P15056 | |
| FNIDPAEPELRPHPL | 421 | P50406 | |
| SPPVHEATQPEPTER | 91 | Q9Y2D5 | |
| LHLFDPTLEPVTEPP | 1011 | Q8NHU2 | |
| LGDIPQAPHDSPPVS | 546 | Q86VW2 | |
| ESTPIPPAAENKLHP | 1656 | Q6UB99 | |
| SPDPDLVPDHSLETP | 521 | O00478 | |
| APEPTHLLQPTEVPG | 51 | A8MQ03 | |
| EPAPPSPESHSPRDL | 161 | Q8NC06 | |
| PDPTVSCLDDPSHLP | 271 | Q9UIF9 | |
| DPAVARQHRPLPSTP | 781 | Q12774 | |
| RPPVPAEAEHRPEST | 531 | Q14687 | |
| PRQPEASFEPHPSVT | 176 | P54259 | |
| AERPEHPLQPLPKSA | 666 | A8MVX0 | |
| HSLLSNPPDPDEPSE | 781 | Q9P2G1 | |
| PFSNPSLAPEDHKEP | 736 | Q9Y2T1 | |
| QPKPAPEASSLEEPH | 271 | Q5JTC6 | |
| HPREVDPFILSLPPS | 1311 | Q9UKA4 | |
| LSPPKRDFPTAEEPH | 146 | Q8WZ64 | |
| PPLAVPQRPNSDAHD | 411 | Q3SXY8 | |
| DPTRSPFPSQHLEAP | 311 | P11532 | |
| PLPDPASASPLHREE | 31 | P56555 | |
| APARESLEIQHPPPL | 626 | Q9NVE4 | |
| IPESPSPAPSLEENH | 371 | Q96NX9 | |
| PHQDADPLKPREPAI | 766 | Q8WUJ3 | |
| EAEPLPASPEAPAHS | 1256 | A7MBM2 | |
| GHEASLQLRPPPEPS | 1211 | Q14004 | |
| DHIPLPRPQSAAPET | 351 | P32121 | |
| PKPESREHIPSVEPQ | 911 | Q8IXJ9 | |
| EPLDSAPARPGHAQP | 166 | Q9UKP4 | |
| RPHVQLSPAPPGEEE | 751 | Q07912 | |
| APPSVHLSAEPPLEA | 231 | Q6UXK2 | |
| HLSAEPPLEAPGTPL | 236 | Q6UXK2 | |
| SPDPQAVHSLEEPLP | 216 | A6NNM3 | |
| SPDPQAVHSLEEPLP | 216 | A6NJZ7 | |
| PPITPRAAPLHSFDE | 191 | Q86VS3 | |
| EVPHKAQELPAPTPS | 476 | Q6IPM2 | |
| LHQDRSSPPPPLPER | 686 | Q9Y2R2 | |
| LGSQPHEDREPVDPT | 1811 | Q14573 | |
| DPETEDPNHLPPDRD | 341 | Q15011 | |
| PPVSLLPHEKDQPRA | 196 | Q8WYB5 | |
| LPHEKDQPRADPIPI | 201 | Q8WYB5 | |
| DNHSPVPIITPTDPI | 2016 | O00763 | |
| DPIPQRHRAATSEEP | 736 | Q96PE2 | |
| ERALPEALPPPATAH | 886 | Q96PE2 | |
| DVLRAVPHPDSQPDT | 96 | P00746 | |
| RLHDDPPQKPPRSIT | 946 | Q7Z6G8 | |
| HGPPTETLPTPRERN | 536 | Q96GW7 | |
| LEPPETGVSHLRPEP | 236 | Q5HY64 | |
| QAPPESSVSHLRPEP | 536 | Q5HY64 | |
| PETRVSHLRPEPPET | 611 | Q5HY64 | |
| ITTNHRPSPDPEQRP | 186 | P41212 | |
| APRIDPPPLITAVAH | 3196 | Q96JQ0 | |
| TEDPTLVGPPLHTPE | 311 | Q9BQK8 | |
| QKSLRDPNPEHEPEP | 416 | Q9BQK8 | |
| DPNPEHEPEPTLDTV | 421 | Q9BQK8 | |
| PRESPQLHERETPRP | 466 | Q9BR39 | |
| EALQAPPAPSREPEV | 546 | Q9BR39 | |
| EVVRPDHPALPPLDN | 201 | Q9UMX2 | |
| PSEPARQPESHPEET | 511 | P56524 | |
| PEPASPQLLETPIHA | 1771 | Q14676 | |
| DPALVHQRPAPPSTV | 96 | Q13261 | |
| IITPREDEDPHRPPT | 491 | Q9H089 | |
| PPEEDAPHSLRSDLP | 156 | O43187 | |
| LTLDPEHQPEETPAP | 41 | Q93015 | |
| EQASEPPRPAEHLEP | 666 | Q9H8L6 | |
| PRPETLHPNPAGLQE | 761 | Q9NR82 | |
| VGPNPEPVLSPRHEE | 356 | Q5VZ46 | |
| LPPQPPARAAELTDE | 826 | Q9UPA5 | |
| PELPEPAQPSEAHAR | 56 | Q6ZVX7 | |
| EELSARTPTHQPPKP | 196 | Q96F63 | |
| QSPEPTEPHPRALAP | 296 | Q9UIS9 | |
| PLPDDISPQKVLHPD | 3646 | Q9Y6V0 | |
| ERRAEVPTAHPSPSP | 146 | Q15116 | |
| PRLPPAAVPSHSDNE | 4146 | Q9NYQ8 | |
| VLDDSPAPPAPFEHR | 486 | Q32MK0 | |
| IHDRDSVGSQPPLPP | 986 | Q5VY43 | |
| PAARPPEPTAERAHS | 61 | Q4G0M1 | |
| ETPLEPHTSESPLVP | 46 | A6H8Z2 | |
| HPEPPETGVSHLRPE | 296 | Q8NA70 | |
| DLPPEAPQTHRASEP | 991 | Q8WXX7 | |
| STALRTTDPPPEHPE | 381 | Q96QE4 | |
| AILDEPQGLSPPPSH | 1051 | P08151 | |
| HRLPVEQAPSEPLDP | 226 | Q6ZNW5 | |
| APERHSPIQNLDPPL | 1831 | Q9UMN6 | |
| ARSHKEPPSPADVPE | 341 | Q86VP3 | |
| HSVEPLRDPNPSDLL | 481 | Q68DK7 | |
| VAHRPQSPPAEAVIP | 1436 | P42694 | |
| QQLDRVDETPGPPHP | 251 | O95402 | |
| EPVHLPQTVRLAEPP | 4606 | Q5VST9 | |
| ELPEDPPAAPATQRV | 146 | P06401 | |
| EPLGSPAHEQLTPPS | 521 | Q8IUM7 | |
| EETAPPVIAPRPDHT | 176 | Q13177 | |
| PVLDGPPQDDLSHPR | 591 | Q8N264 | |
| APAEESKPAPSPHEE | 276 | Q8NA61 | |
| ELETVAPPEPEPSHI | 261 | A1A4V9 | |
| APPEPEPSHIHVLRA | 266 | A1A4V9 | |
| KRDALAASHEPPPEP | 126 | Q9GZV1 | |
| EEPPAAAPTPTHRRT | 1516 | O95996 | |
| LSEPEPSEPPAVHPR | 1586 | O95996 | |
| TDLEIPPPGTPHSEL | 1791 | Q9ULT8 | |
| PPHSRSLPDILGQPE | 596 | P32927 | |
| SQPDHGRLSPPEAPD | 596 | Q9BWV1 | |
| PRLHLETPQPSPQEG | 131 | O14613 | |
| KTDHPSALLRDPPEP | 386 | P09603 | |
| ISAEPAPSPETHIIP | 3966 | Q9UFH2 | |
| TEPLNPDLRETPHPE | 86 | I3L273 | |
| PDLRETPHPESPETP | 91 | I3L273 | |
| SDTPLEGEPPLSHNP | 441 | Q5T0N1 | |
| PVQDLDDDTPPSPAH | 86 | O00409 | |
| RLTHLSETEPPPAPE | 521 | Q8IZJ3 | |
| ERLLLDGPPPHSPET | 1966 | Q3T8J9 | |
| TPPHRTVPEDTDPEL | 746 | Q8TBE0 | |
| PRPQAAEPPDHLTIT | 96 | Q96L14 | |
| HPLTRVAPQPPGEDD | 171 | O43281 | |
| PEPSSLPIPHQELLR | 811 | Q12852 | |
| IKPSDPVERNSHAPP | 881 | Q86V48 | |
| RPSRIDPQEPTHSKP | 626 | Q96P31 | |
| AGSPTPQLLPPIEEH | 36 | A2RUH7 | |
| SHLEEEQPPAPESPE | 336 | O60307 | |
| EQPPAPESPESRALV | 341 | O60307 | |
| LPEPHDRPLALPLSD | 116 | Q8NDX9 | |
| QPDPSLPPLTISNHD | 506 | P32019 | |
| RRVSSLHPEPPKAPE | 551 | Q5JRC9 | |
| DSHDEEVSPTPPNPV | 76 | P31321 | |
| EERSDTPEVHPPLPI | 501 | Q03164 | |
| PPDGPHLPIQTAELT | 91 | Q02535 | |
| NTFRPEVHLLPPPSE | 211 | P01877 | |
| PEAHQPVSILTSPEP | 721 | Q5T1A1 | |
| SAEPAPSPEGHIIPQ | 3991 | Q9NYC9 | |
| VSPSEQALPPHLEPA | 316 | Q8IX15 | |
| PEPPAVPSEVELQHL | 296 | I6L899 | |
| ESLAAEPREPQQPPS | 281 | Q9NZ56 | |
| PSDPRLHPPREAEST | 66 | Q9BTL4 | |
| SSGAPPPDEIHPLEI | 1141 | Q10571 | |
| PLFSETIHDPNPCPE | 196 | P33527 | |
| SPVLDPPPHLEPNRS | 711 | Q9NXL9 | |
| PTAPEAEPEAPISHP | 1596 | Q9NQT8 | |
| EPKESLQEPHSPALP | 1431 | Q8N2Y8 | |
| LVTPSADILEPSPHP | 296 | P58004 | |
| APPQLEDEEPAFPHT | 56 | Q93008 | |
| DPASASPEPVPHILA | 171 | Q5JUK2 | |
| DDPSPVPHPELSLAE | 241 | Q96N64 | |
| PEHLDTPDTPPRSQA | 291 | Q6ZMC9 | |
| ESPSHLLEESPPNPC | 196 | Q96R06 | |
| ACPPTQEHPLPNDRT | 906 | Q96R06 | |
| IAPADPDTAIVHPVP | 441 | Q96D71 | |
| TDSEQRELPPEIPSH | 1241 | Q8WUY3 | |
| SPLASPDPRTKHPQD | 156 | B4DYI2 | |
| PDPRTKHPQDLASTP | 161 | B4DYI2 | |
| HSPSIPPPADVTEEE | 71 | Q9NWS0 | |
| DAPPPQDEHTTIIDR | 986 | Q8N3T6 | |
| DTAIPFHSTDDPPRP | 141 | O75478 | |
| PDNRSSAPPRKDVPH | 316 | Q9ULZ9 | |
| SPDPQAVHSLEEPLP | 216 | Q9UFD9 | |
| LSASQPPEPSLPLEH | 181 | Q5VVP1 | |
| TSPLLETQAEDHPPR | 601 | Q9Y6U3 | |
| SPPSPLGLIEAPEHA | 76 | Q5QGS0 | |
| IHLRPPSPEIQAADP | 526 | Q5JWF2 | |
| AHLVPPPSDPLGSEL | 621 | Q9Y6C5 | |
| DEPPSPRHPLAPSAE | 706 | Q9BRB3 | |
| LSASQPPEPSLPLEH | 181 | Q8IWB4 | |
| HLLPLPESAPALPTE | 1111 | P58107 | |
| DVSQDPTLPRTEDHP | 71 | P36954 | |
| RPVLPTQSAHDPPAV | 31 | P04278 | |
| KNPPEPPANTARHSL | 506 | Q14190 | |
| LNDPALSPDIPPAHS | 1671 | O60292 | |
| DPERPPVHDQLQDPR | 2526 | Q7Z333 | |
| APREETRLENPATHP | 616 | Q2M3G4 | |
| AETPEPPPLSDHIRN | 11 | Q9NY91 | |
| PPHHIERVEPSLQPE | 246 | Q6ZUB0 | |
| VEARPPLSPERAPEH | 1291 | Q9UPS6 | |
| PEHPREVLVPAPHSA | 481 | O75626 | |
| VPSPEPRLLEPSDHA | 2531 | Q9P2P6 | |
| VSPDPLLSPTAHPLD | 1436 | A1L4H1 | |
| EIHDPPPEAVQTVTP | 1371 | Q6Q759 | |
| PELRLLNDHSAPETP | 1226 | Q8TER0 | |
| LNDHSAPETPTQPPR | 1231 | Q8TER0 | |
| SHQANRSPPLDSDPP | 1406 | Q8IY92 | |
| EEEAHRPPSPTEAPT | 661 | P35611 | |
| PLQLEEPLEPSPLRH | 1046 | Q0VD83 | |
| EPLEPSPLRHDGTPV | 1051 | Q0VD83 | |
| LSPPLPHEERAQSPP | 471 | Q9UPV0 | |
| PKSRIADLPPANPDH | 621 | O75746 | |
| LTRHPPPVPAEDPAA | 1031 | Q8IUL8 | |
| ELTPPEHLSDLPPFS | 1031 | Q86XI2 | |
| AQAREPTASPVPVPH | 296 | Q96F05 | |
| EALHSSPEDPVLPRP | 286 | Q15735 | |
| PALAPHLPTEDATLP | 61 | Q6S5L8 | |
| EPEAAQRHDPAPRNP | 191 | Q6ZS11 | |
| LSASQPPEPSLPLEH | 181 | Q5VYP0 | |
| PKTDEERPPVEHSPE | 16 | Q15170 | |
| ERPPVEHSPEKQSPE | 21 | Q15170 | |
| PDVIDPSAHETPKQP | 636 | O94967 | |
| PPHHIERVEPSLQPE | 246 | P0C874 | |
| PESRGHVSPQVELPP | 346 | Q8N5D0 | |
| ATLDPLALDREPPPH | 56 | Q6ZMY6 | |
| LSASQPPEPSLPLEH | 181 | Q5TZJ5 | |
| LSASQPPEPSLPLEH | 181 | Q5VU36 | |
| HTKDVRPAPAEEPLP | 371 | Q92766 | |
| APPEDEDPALSPHLL | 396 | A6NFA1 | |
| PRHTEIPAEFPPLDD | 141 | P84022 | |
| PILDRPHPVSSPVVQ | 981 | Q6ZQQ2 | |
| EPQDRVPPSGLHVPA | 841 | Q6ZMY3 | |
| PSSEETRPPHVNPDR | 31 | Q9UIG5 | |
| ELPPDPVEAEAAPHT | 536 | O15015 | |
| PHECASPLRLDVPPE | 811 | Q9H3T2 | |
| EPESPRHRPKDAATP | 196 | Q92620 | |
| SEPAPQPHRPLDPLT | 71 | Q8N2W9 | |
| PPTHAAPLPAVIAES | 166 | Q9BYW2 | |
| HQFLTPDEAPSPPRL | 436 | Q8IZN3 | |
| LPSHCPEDDRPEAIP | 2946 | Q96JG9 | |
| SERSLTPGQEHPPPA | 261 | Q17R98 | |
| LQRSETEPHLDPPPE | 181 | O14668 | |
| LHEEPPQASPSRPLN | 46 | Q8N9L1 | |
| GPASPPEEDPERTKH | 406 | Q96KM6 | |
| ADPPPKHRSQDSLVP | 816 | Q96KM6 | |
| TLPSDSPRHLPEPEG | 91 | Q13470 | |
| VAFIHTDLPEPPPSL | 691 | Q9ULC8 | |
| PTLRHPSPQGEELHP | 161 | Q6ZR37 | |
| HPAPALAPNESPKDS | 296 | Q7RTT9 | |
| EPRTSSHADPPEAEP | 1186 | Q5SXM2 | |
| HDVQLEDPSPPAPAA | 1666 | P52746 | |
| VPQSAPPEPHREETV | 111 | Q9H4A3 | |
| EPEADQHLLPPTLPT | 591 | Q9Y3S1 | |
| NESVPRPPLHPADVP | 556 | Q8TDI7 | |
| PDHTSTLEPPRLPQR | 531 | Q9H6R7 | |
| PIHTPQRSVPEVDPA | 161 | Q6ZVM7 | |
| PLDVPHIRLDSPPSF | 226 | Q86YW5 | |
| EAPVHSPEAPEKDPL | 126 | Q9ULD5 | |
| HRGQPPELAALPTPE | 761 | Q8NFY4 | |
| EEAAPPSPRPQSRAH | 66 | Q6ZTI0 | |
| TVVIPPAPEEEQPSH | 116 | Q8IV31 | |
| PAPEEEQPSHPEGSR | 121 | Q8IV31 | |
| LVSLPHQLPEASEPP | 791 | Q9P275 | |
| TQDFTHPPDQSPLRP | 426 | Q9BYX2 | |
| HPPDQSPLRPDAANR | 431 | Q9BYX2 | |
| LPPPPANHNDELRLT | 551 | Q9ULJ6 | |
| PPLAPQQATSEPRAH | 156 | Q8TB05 | |
| DPPRPNLTSHPDGSE | 46 | Q8WTR7 | |
| PEELPASPLPEALHL | 471 | O14686 | |
| HLSPRPEEPHLSPQA | 751 | O14686 | |
| PEEPHLSPQAEEPHL | 756 | O14686 | |
| LSPQAEEPHLSPQPE | 761 | O14686 | |
| LSPQTEEPHLSPVPE | 806 | O14686 | |
| EEPHLSPVPEEPCLS | 811 | O14686 | |
| EPCLSPQPEESHLSP | 821 | O14686 | |
| PQPEESHLSPQSEEP | 826 | O14686 | |
| EEPREFPPHSTKPQE | 551 | Q86W25 | |
| DERELHPAGTPEPPS | 261 | O15069 | |
| PIGPPSEPTHLAVED | 866 | Q14896 | |
| DSASQHQEELPPPPL | 181 | Q96PU5 |